Tissue hypoxia has been shown to regulate EFNA3 [75] that is a clinical prognostic and therapeutic predictor in lung adenocarcinoma and hepatocellular carcinoma [76, 77]. This evidence concerns the gene EFNA3 and hepatocellular carcinoma.